FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding.